|Bid||29.00 x 17700|
|Ask||29.40 x 17000|
|Day's Range||29.00 - 29.00|
|52 Week Range||15.90 - 36.00|
|Beta (5Y Monthly)||0.68|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||0.32 (1.11%)|
|Ex-Dividend Date||Jun 17, 2020|
|1y Target Est||N/A|
Luminex (LMNX) submits an EUA request to the FDA for its first multi-antigen IgG assay.
At the end of February we announced the arrival of the first US recession since 2009 and we predicted that the market will decline by at least 20% in (Recession is Imminent: We Need A Travel Ban NOW). In these volatile markets we scrutinize hedge fund filings to get a reading on which direction each […]
Hedge funds don't get the respect they used to get. Nowadays investors prefer passive funds over actively managed funds. One thing they don't realize is that 100% of the passive funds didn't see the coronavirus recession coming, but a lot of hedge funds did. Even we published an article near the end of February and […]
Shares in Luminex Corporation (NASDAQ: LMNX) are trading 13.5% lower as of 3:05 p.m. EDT on Friday after the company announced the pricing of its offering of $260 million of 3% convertible senior notes due 2025. The conversion rate on the healthcare company's senior notes is 22.8918 shares of common stock per $1,000 principal amount of convertible notes, which is equivalent to an initial conversion price of $43.68 per share. Luminex is using $34.7 million of the proceeds to pay for its hedges and the remaining money will go to its balance sheet for general use.
With me today is Homi Shamir, our President and CEO. Certain statements made during the course of today's call, may not be purely historical and consequently may be forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, and the Company claims the projections provided by Section 21E of the Securities Exchange Act for such statements.
Luminex's (LMNX) fourth-quarter earnings benefit from higher revenues and solid performance across System Sales, Service and Other Revenues. However, gross margin contraction remains a woe.
Does Luminex Corporation (NASDAQ:LMNX) represent a good buying opportunity at the moment? Let’s quickly check the hedge fund interest towards the company. Hedge fund firms constantly search out bright intellectuals and highly-experienced employees and throw away millions of dollars on satellite photos and other research activities, so it is no wonder why they tend to […]